103 results
Page 5 of 6
8-K
EX-1.1
a8p7 zrxmmitg7
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
8-K
EX-99.1
6abw8f5k1o082l2mcdb3
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
8-K
EX-99.1
gc31bf
9 Aug 18
Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
ri1iahfca3 q1
12 Jun 18
Viking Therapeutics Announces Closing of Public Offering of Common Stock
7:10am
8-K
EX-1.1
ni4p872f0x y4vjjb
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
8-K
EX-99.1
z5kdghr0x3op
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
8-K
EX-99.1
deqqha 53
9 May 18
Viking Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B4
cjvd8
8 Apr 16
Prospectus supplement with pricing info
12:00am